• Facebook
  • Twitter
  • Instagram
  • YouTube
Skip to content
METUPUK

METUPUK

Dying For A Cure

Donate Now
  • Home
  • #DarkerPink
    • WHO REALLY CARES?
    • #DarkerPink Exhibition
    • #DarkerPink TV ad 2022
  • About us
    • Welcome to METUPUK
    • Who are we? Our Mission Statement
    • Why are we doing this?
    • Red flag #SBCinfographic
    • International Allies – The ABC Global Alliance
    • Our friends not forgotten
    • METUPUK Strategy
    • METUPUK – around the UK
      • MBC Wales
        • MBC Wales – About Us
        • MBC Wales – The Gammon Dragon
      • MBC Scotland (coming soon)
      • MBC N.I. (coming soon)
  • Aims & Objectives
    • Awareness & Education
    • Research & Access to drugs
    • Patient Treatment and Care
  • Research & Trials
    • Clinical trials
    • Treatment Lines
    • METUPUKs #TrodelvyNow Campaign
  • Help us
    • Resources
    • I Am The 31
    • METUPUK Newsletter
    • Join us
  • News/Blog
METUPUK

METUPUK

Donate Now
  • Home
  • #DarkerPink
    • WHO REALLY CARES?
    • #DarkerPink Exhibition
    • #DarkerPink TV ad 2022
  • About us
    • Welcome to METUPUK
    • Who are we? Our Mission Statement
    • Why are we doing this?
    • Red flag #SBCinfographic
    • International Allies – The ABC Global Alliance
    • Our friends not forgotten
    • METUPUK Strategy
    • METUPUK – around the UK
      • MBC Wales
        • MBC Wales – About Us
        • MBC Wales – The Gammon Dragon
      • MBC Scotland (coming soon)
      • MBC N.I. (coming soon)
  • Aims & Objectives
    • Awareness & Education
    • Research & Access to drugs
    • Patient Treatment and Care
  • Research & Trials
    • Clinical trials
    • Treatment Lines
    • METUPUKs #TrodelvyNow Campaign
  • Help us
    • Resources
    • I Am The 31
    • METUPUK Newsletter
    • Join us
  • News/Blog

breast cancer drug approval

Home > Posts tagged breast cancer drug approval

Pembrolizumab approved by the SMC – Scottish Medicines Consortium

October 10, 2022December 20, 2022 metupuk

METUPUK welcomes the Scottish Medicines Consortium (SMC) decision to accept pembrolizumab (Keytruda, Merck Sharp and Dohme) plus chemotherapy (paclitaxel or nab-paclitaxel) for use on the NHS in Scotland.  Pembrolizumab is

continue reading
Uncategorizedbreast cancer drug approval, drug access, metastatic breast cancer, Scottish Medicines Consortium, secondary breast cancer

Follow us on the Socials

Get involved and help make a difference:

Facebook
Twitter
Instagram

Latest tweets

Tweets by @metupukorg

METUPUK Strategy Doc

METUPUK Volunteer Agreement

METUPUK Conflict of Interest

Follow us on socials

  • Facebook
  • Twitter
  • Instagram
  • YouTube

Latest from the News/Blog

  • Trustees’ Week by Madeleine Meynell November 6, 2024
  • Why I volunteer with METUPUK… October 30, 2024
  • I’m a 51 year old NHS nurse and 18 months ago I was told i had MBC… October 29, 2024
  • I remember the 22nd April 2021 very clearly… October 28, 2024
  • Life has a way of throwing curveballs when you least expect it… October 28, 2024
Copyright MET UP UK © Charity number 1196494. All right reserved.